title: Preconditioning with thrombin can be protective or worsen damage after endothelin-1-induced focal ischemia in rats.
abstract: The serine protease thrombin has shown direct neuroprotective and neurotoxic effects on brain tissue in cerebral ischemia. Previous data suggested that thrombin-induced protection in vivo can be achieved by preconditioning rather than by acute treatment. In the current work, we used a model of mild ischemia to investigate the effects of preischemic intracerebral thrombin injection on neural damage. By intracerebral injection of endothelin-1 in freely moving animals, we achieved middle cerebral artery occlusion (MCAO), and 7 days postischemia we performed histological quantification of the infarct areas. Thrombin was injected as a preconditioning stimulus intracerebrally 7 days or 2 and 3 days before ischemia. For acute treatment, thrombin was injected 20 min before MCAO. Thrombin induced significant neuroprotection when given 7 days before endothelin-1-induced MCAO but was deleterious when given 2 and 3 days before the insult. The deleterious effect was not seen when thrombin was given acutely before ischemia. Our data demonstrate that preconditioning with thrombin can protect against damage or worsen ischemic damage. Its effect depended on the time interval between thrombin injection and insult. A low dose of thrombin did not induce a major deleterious effect in the acute phase of the infarct development after mild transient ischemia.
authors.affiliation: Institute for Neurobiochemistry, Otto-von-Guericke University Medical Faculty, Magdeburg, Germany.
authors.forename: Petra
authors.initials: P
authors.lastname: Henrich-Noack
authors.forename: Frank
authors.initials: F
authors.lastname: Striggow
authors.forename: Georg
authors.initials: G
authors.lastname: Reiser
authors.forename: Klaus G
authors.initials: KG
authors.lastname: Reymann
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D020520:Brain Infarction / Q000209:etiology* / Q000517:prevention & control*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D019332:Endothelin-1; D006490:Hemostatics / Q000008:administration & dosage*; D020925:Hypoxia-Ischemia, Brain / Q000139:chemically induced / Q000150:complications / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D018709:Statistics, Nonparametric; D013917:Thrombin / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D019332:Endothelin-1; D006490:Hemostatics; D013917:Thrombin